Dr. Scott R. May is a patent agent in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's patents and innovations practice. His broad scientific expertise spans many fields in the life sciences including mammalian genetics and genomics, neurobiology, development, molecular and cell biology, cardiovascular function, and virology. Scott applies this interdisciplinary knowledge to patent prosecution, freedom to operate and intellectual property matters for clients in the pharmaceutical, biotechnology, diagnostics, life sciences, and genomics industries.
Prior to joining the firm, Scott was a postdoctoral fellow in the laboratory of Dennis O’Leary at the Salk Institute for Biological Studies where he led research projects investigating transcription factors that regulate area-specific patterning of the cerebral cortex. During an earlier post-doctoral appointment at UCSF, Scott’s research focused on the mechanisms through which primary cilia transduce hedgehog signals as well as studying neural migration defects in mouse models of autism and schizophrenia.
Scott completed his Ph.D. in genetics from Duke University while conducting a forward genetic screen in mice to uncover novel mutations disrupting forebrain development and then positionally-cloning the affected genes. In addition to enabling Scott to hone his skills in bioinformatics, functional genetics, and cell and developmental biology, these mouse models opened avenues into foundational investigations of the underlying causes of neurodevelopmental and neurodegenerative diseases. Molecular therapeutic strategies were subsequently designed and tested in these models. As such, Scott has vast experience identifying molecular pathways and studying stem-cell patterning, cell migration, neural connectivity, and behavioral characterization within animal models of autism, schizophrenia, ciliopathies, lissencephaly, and seizure disorders.
Dr. Scott R. May is a patent agent in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's patents and innovations practice. His broad scientific expertise spans many fields in the life sciences including mammalian genetics and genomics, neurobiology, development, molecular and cell biology, cardiovascular function, and virology. Scott applies this interdisciplinary knowledge to patent prosecution, freedom to operate and intellectual property matters for clients in the pharmaceutical, biotechnology, diagnostics, life sciences, and genomics industries.
Prior to joining the firm, Scott was a postdoctoral fellow in the laboratory of Dennis O’Leary at the Salk Institute for Biological Studies where he led research projects investigating transcription factors that regulate area-specific patterning of the cerebral cortex. During an earlier post-doctoral appointment at UCSF, Scott’s research focused on the mechanisms through which primary cilia transduce hedgehog signals as well as studying neural migration defects in mouse models of autism and schizophrenia.
Scott completed his Ph.D. in genetics from Duke University while conducting a forward genetic screen in mice to uncover novel mutations disrupting forebrain development and then positionally-cloning the affected genes. In addition to enabling Scott to hone his skills in bioinformatics, functional genetics, and cell and developmental biology, these mouse models opened avenues into foundational investigations of the underlying causes of neurodevelopmental and neurodegenerative diseases. Molecular therapeutic strategies were subsequently designed and tested in these models. As such, Scott has vast experience identifying molecular pathways and studying stem-cell patterning, cell migration, neural connectivity, and behavioral characterization within animal models of autism, schizophrenia, ciliopathies, lissencephaly, and seizure disorders.
Dissertation: “The Genetic Analysis of Forebrain and Cardiovascular Development in the Mouse”
Dissertation: “The Genetic Analysis of Forebrain and Cardiovascular Development in the Mouse”